A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral SCY-078 vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2017

At a glance

  • Drugs SCY 078 (Primary) ; Fluconazole
  • Indications Vulvovaginal candidiasis
  • Focus Therapeutic Use
  • Acronyms DOVE
  • Sponsors SCYNEXIS
  • Most Recent Events

    • 08 Aug 2017 New trial record
    • 03 Aug 2017 According to a SCYNEXIS media release, first patient has been dosed in this study and top-line results are expected in mid-2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top